• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number VBJR061502A
Device Problems Entrapment of Device (1212); Detachment of Device or Device Component (2907)
Patient Problem Perforation of Vessels (2135)
Event Date 05/10/2019
Event Type  Injury  
Manufacturer Narrative
Review of device manufacturing record history confirmed device met pre-release specifications.The device was discarded at user facility.Therefore, direct product analysis was not possible.Instructions for use (ifu) for gore® viabahn® endoprosthesis with heparin bioactive surface states: contraindications: the gore® viabahn® endoprosthesis is contraindicated for non-compliant lesions where full expansion of an angioplasty balloon catheter was not achieved during pre-dilatation, or where lesions cannot be dilated sufficiently to allow passage of the delivery system.
 
Event Description
The following was reported to gore: patient was treated due to an occluded superficial femoral artery (sfa).As reported, this patient had previous surgeries and access from the femoral artery was no longer an option.Pedal approach, with access from the anterior tibial artery was made.After access was obtained, multiple balloon catheters including a 5x15 sterling and 3x200 mustang were used for vessel dilation.A 6fr terumo sheath was then used to advance a 6x15 gore® viabahn® endoprosthesis over a platinum plus wire.As the viabahn device was advanced, it became stuck within the sheath.The physician attempted to pull the device back out.As the viabahn device was manipulated, the wire inside the catheter was broken.The deployment line at the transition was severed.The patient was transferred for surgical repair.The tibial artery was cut down to allow for the constrained viabahn device and sheath to be removed.After the artery was repaired, a second access was made at the popliteal artery, located behind the knee.Wire access was achieved, and two viabahn devices (6x25 and 5x15) were deployed to treat the occlusion in the sfa.Post procedure, the patient was reported to be recovering with pulse (signal) to the foot.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
genevieve begay
1500 n. 4th street
9285263030
MDR Report Key8671202
MDR Text Key147082542
Report Number2017233-2019-00390
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00733132623747
UDI-Public00733132623747
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/05/2022
Device Catalogue NumberVBJR061502A
Device Lot Number20194762
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/05/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/06/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-